105 related articles for article (PubMed ID: 25691721)
1. Proceedings of the 2013 Viral Clearance Symposium (Princeton, NJ).
Roush D; Brorson K; Levy R
PDA J Pharm Sci Technol; 2015; 69(1):140-1. PubMed ID: 25691721
[No Abstract] [Full Text] [Related]
2. 2013 viral clearance symposia - session 5. Conference summary: key discussion and outcomes, pending questions, and proposed experiments.
Blümel J; Roush D
PDA J Pharm Sci Technol; 2015; 69(1):206-10. PubMed ID: 25691728
[No Abstract] [Full Text] [Related]
3. Viral clearance using traditional, well-understood unit operations: session 1.2. Anion exchange chromatography; and session 1.3. Protein a chromatography.
Roush D
PDA J Pharm Sci Technol; 2015; 69(1):154-62. PubMed ID: 25691723
[No Abstract] [Full Text] [Related]
4. Session 2/3: integrated viral clearance strategy and case studies.
Willkommen H
PDA J Pharm Sci Technol; 2015; 69(1):183-94. PubMed ID: 25691726
[No Abstract] [Full Text] [Related]
5. Session 4: overall integrated viral clearance and adventitious agents strategy.
Blümel J; Tounekti O
PDA J Pharm Sci Technol; 2015; 69(1):195-205. PubMed ID: 25691727
[No Abstract] [Full Text] [Related]
6. Summary of 11th Princeton Conference on Cerebrovascular Disease, Nassau Inn, Princeton, NJ, March 5--7, 1978.
McDowell FH; Millikan CH
Stroke; 1978; 9(5):429-39. PubMed ID: 30187
[No Abstract] [Full Text] [Related]
7. Assessment of Antiviral Properties of Peramivir against H7N9 Avian Influenza Virus in an Experimental Mouse Model.
Farooqui A; Huang L; Wu S; Cai Y; Su M; Lin P; Chen W; Fang X; Zhang L; Liu Y; Zeng T; Paquette SG; Khan A; Kelvin AA; Kelvin DJ
Antimicrob Agents Chemother; 2015 Dec; 59(12):7255-64. PubMed ID: 26369969
[TBL] [Abstract][Full Text] [Related]
8. Cirsimaritin inhibits influenza A virus replication by downregulating the NF-κB signal transduction pathway.
Yan H; Wang H; Ma L; Ma X; Yin J; Wu S; Huang H; Li Y
Virol J; 2018 May; 15(1):88. PubMed ID: 29783993
[TBL] [Abstract][Full Text] [Related]
9. Session 1.5: other viral clearance and inactivation approaches (multimodal chromatography, membrane chromatography, chemical precipitation).
Hubbard B
PDA J Pharm Sci Technol; 2015; 69(1):173-82. PubMed ID: 25691725
[No Abstract] [Full Text] [Related]
10. Protein-protein interactions as targets for antiviral chemotherapy.
Loregian A; Marsden HS; Palù G
Rev Med Virol; 2002; 12(4):239-62. PubMed ID: 12125015
[TBL] [Abstract][Full Text] [Related]
11. Risk assessment of recent Egyptian H5N1 influenza viruses.
Arafa AS; Yamada S; Imai M; Watanabe T; Yamayoshi S; Iwatsuki-Horimoto K; Kiso M; Sakai-Tagawa Y; Ito M; Imamura T; Nakajima N; Takahashi K; Zhao D; Oishi K; Yasuhara A; Macken CA; Zhong G; Hanson AP; Fan S; Ping J; Hatta M; Lopes TJ; Suzuki Y; El-Husseiny M; Selim A; Hagag N; Soliman M; Neumann G; Hasegawa H; Kawaoka Y
Sci Rep; 2016 Dec; 6():38388. PubMed ID: 27922116
[TBL] [Abstract][Full Text] [Related]
12. Genetics and demography: notes on the third Princeton conference (Princeton, N. J., October 20-22, 1966).
Post RH
Eugen Q; 1967 Sep; 14(3):199-204. PubMed ID: 4383920
[No Abstract] [Full Text] [Related]
13. Influenza virus nucleoprotein: structure, RNA binding, oligomerization and antiviral drug target.
Chenavas S; Crépin T; Delmas B; Ruigrok RW; Slama-Schwok A
Future Microbiol; 2013 Dec; 8(12):1537-45. PubMed ID: 24266354
[TBL] [Abstract][Full Text] [Related]
14. Non-covalent inhibitors of rhinovirus 3C protease.
Baxter A; Chambers M; Edfeldt F; Edman K; Freeman A; Johansson C; King S; Morley A; Petersen J; Rawlins P; Spadola L; Thong B; Van de Poël H; Williams N
Bioorg Med Chem Lett; 2011 Jan; 21(2):777-80. PubMed ID: 21183345
[TBL] [Abstract][Full Text] [Related]
15. [A report from the Chinese National Fourteenth Symposium on Viral Hepatitis and Liver Diseases].
Zhu HM; Zhang DZ
Zhonghua Gan Zang Bing Za Zhi; 2009 Aug; 17(8):636-7. PubMed ID: 19719931
[No Abstract] [Full Text] [Related]
16. Viral clearance of traditional unit operations: virus-retentive filtration.
Chen Q; Chen D
PDA J Pharm Sci Technol; 2015; 69(1):142-53. PubMed ID: 25691722
[No Abstract] [Full Text] [Related]
17. [AIDS and a new microbicidal gel].
Nau JY
Rev Med Suisse; 2010 Aug; 6(259):1562-3. PubMed ID: 20873439
[No Abstract] [Full Text] [Related]
18. Filovirus proteins for antiviral drug discovery: Structure/function of proteins involved in assembly and budding.
Martin B; Reynard O; Volchkov V; Decroly E
Antiviral Res; 2018 Feb; 150():183-192. PubMed ID: 29305306
[TBL] [Abstract][Full Text] [Related]
19. Understanding the molecular targets for new therapeutical agents in hepatitis c infection.
Vagu C; Sultana C; Ruţă S
Roum Arch Microbiol Immunol; 2013; 72(1):5-24. PubMed ID: 23947011
[TBL] [Abstract][Full Text] [Related]
20. Protein kinase inhibitors of the quinazoline class exert anti-cytomegaloviral activity in vitro and in vivo.
Schleiss M; Eickhoff J; Auerochs S; Leis M; Abele S; Rechter S; Choi Y; Anderson J; Scott G; Rawlinson W; Michel D; Ensminger S; Klebl B; Stamminger T; Marschall M
Antiviral Res; 2008 Jul; 79(1):49-61. PubMed ID: 18329738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
